Barely Significant
← all excerpts

Uptake of biosimilars in China: a retrospective analysis of the case of trastuzumab from 2018 to 2023.

Glob Health Res Policy · 2024 · PMC11453021 · PMID 39367503

Europe PMCDOI
1
hedged sentence
0.0010
closest p · 0.0× alpha
0.0010
boldest claim

The sentences

an increasing trendP < 0.001actually significant
From March 2018 to January 2020, the overall trastuzumab consumption volume showed an increasing trend, with an average monthly growth rate of 2.5% ( P < 0.001).

also in 25,605 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.